Verapamil (VP) improves the outcome after renal transplantation (CRT)

Calcium antagonists (CATs) have a role in the management of certain types of renal insufficiency [6, 15]. These include prophylaxis against post‐transplant‐associated acute renal failure and cyclosporine A (CsA)‐induced renal dysfunction. For the transplanted kidney, CATs may be beneficial in several settings. First, a CAT during organ procurement protects the kidney during ischemic periods [9]. Second, CATs given perioperatively protect the kidney during reperfusion and early after transplantation [2]. Third, CATs also offer protection against CsA nephrotoxicity [1].

[1]  A. Sagalowsky,et al.  Verapamil improves the outcome after cadaver renal transplantation. , 1991, Journal of the American Society of Nephrology : JASN.

[2]  J. Reisch,et al.  Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil. , 1989, Transplantation.

[3]  K. Diller,et al.  In vivo fluorescence microscopy of kidney subcapsular blood flow in mice. Effects of cyclosporine, (NVA2)-cyclosporine, and isradipine, a new calcium antagonist. , 1988, Transplantation.

[4]  I. Dawidson,et al.  Cyclosporine A induces decreased blood flow in cadaveric kidney transplants. , 1988, Transplantation proceedings.

[5]  K. Diller,et al.  PROTECTION AGAINST CYCLOSPORINE‐INDUCED IMPAIRMENT OF RENAL MICROCIRCULATION BY VERAPAMIL IN MICE , 1988, Transplantation.

[6]  M. Epstein,et al.  Renal hemodynamic effects of calcium antagonists. , 1987, Journal of cardiovascular pharmacology.

[7]  R. Schrier,et al.  Cellular calcium in ischemic acute renal failure: role of calcium entry blockers. , 1987, Kidney international.

[8]  H. Neumayer,et al.  Prevention of delayed graft function in cadaver kidney transplants by diltiazem: outcome of two prospective, randomized clinical trials. , 1987, Journal of cardiovascular pharmacology.

[9]  H. Neumayer,et al.  DILTIAZEM AND ECONOMIC USE OF CYCLOSPORIN , 1986, The Lancet.

[10]  K. Renton.  Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil. , 1985, Biochemical pharmacology.

[11]  R. Wait,et al.  Verapamil inhibition of lymphocyte proliferation and function in vitro. , 1985, The Journal of surgical research.